2018

  • Dental opioids and youth addiction

    In teenagers and young adults, receiving opioids from dental providers is linked with elevated risk for continued opioid use and abuse, a Stanford study has found.

  • Progress in peanut-allergy immunotherapy

    As immunotherapy for peanut allergy advances, a Stanford allergy expert discusses what that means for parents, providers and the future of allergy treatments.

  • Possible therapy for surgical adhesions

    Fibrous adhesions that form after abdominal surgery may be preventable or treatable, according to Stanford study. Adhesions affect most surgical patients, and treating them costs over $1 billion annually.

  • Home videos for autism diagnosis

    Algorithms generated through machine learning can sort through observations of children’s behavior in short home videos to determine if the children have autism, a Stanford study has shown.

  • Algorithm success in screening for disease

    In a matter of seconds, a new algorithm read chest X-rays for 14 pathologies, performing as well as radiologists in most cases, a Stanford-led study says.

  • Stanford Medicine magazine and high-tech

    Stanford Medicine is applying high-tech approaches to reshape medical research, training, diagnostics and treatment — without losing the essential human touch.

  • EHRs for Fido

    A team led by scientists at the School of Medicine has developed an algorithm that can read the typed-out notes from veterinarians and predict specific diseases that the animal may have.

  • New country, new bone marrow

    Ikkei Takeuchi suffered from unexplained bone marrow failure. But with the help of his little brother and doctors at Lucile Packard Children’s Hospital Stanford, he’s on the road to recovery.

  • Air Cube touches down at hospital

    The new Stanford Hospital gets its first commissioned piece of art.

  • No survival benefit with new cancer drug

    Cisplatin chemotherapy can bring lasting adverse health effects, but a new, presumably less-toxic alternative is not as effective at promoting survival, according to a large, Stanford-led trial.